YOQNEAM, ISRAEL--(Marketwire - November 21, 2008) - Given Imaging Ltd. (NASDAQ: GIVN) today announced that the French Ministry of Health has concluded the reimbursement process for PillCam® SB and set a pricing level of 418EUR without VAT. The decision was published in the Journal Officiel on November 21, 2008. Now all of France’s 64 million citizens will have reimbursable access to Pillcam SB for the following indications:
